Specific adoptive immunotherapy.
Greenberg
P D
PD
Department of Medicine, University of Washington, Seattle.
Klarnet
J P
JP
Kern
D E
DE
Okuno
K
K
Riddell
S
S
Cheever
M A
MA
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D002460:Cell Line; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005622:Friend murine leukemia virus; D007116:Immunization, Passive; D004915:Leukemia, Erythroblastic, Acute; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000628:therapy*; D008212:Lymphocyte Depletion; D008262:Macrophage Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology / Q000637:transplantation*
D000951:Antigens, Neoplasm; D003520:Cyclophosphamide